Adeshwar Meditex Ltd Posts Rs 2.06 Crore Profit in FY25
By Ankur Chandra | Updated at: May 31, 2025 10:41 PM IST
Mumbai, May 28, 2025 – Adeshwar Meditex Ltd (BSE: 543309) released its financial reports for the financial year ended March 31, 2025. The reports show that the company slightly increased its profits.
Key Financial Highlights (₹ in Lakh)
| Particulars | H2 FY25 | H2 FY24 | FY25 | FY24 |
|---|---|---|---|---|
| Revenue from Operations | 3,744.85 | 3,358.55 | 8,371.31 | 7,985.02 |
| Other Income | 17.41 | 4.84 | 25.86 | 13.28 |
| Total Income | 3,762.26 | 3,363.39 | 8,397.17 | 7,998.30 |
| Total Expenses | 3,580.15 | 3,182.08 | 8,117.83 | 7,719.76 |
| Profit Before Tax | 182.11 | 181.31 | 279.34 | 278.54 |
| Current Tax | 57.50 | 55.00 | 82.50 | 80.00 |
| Deferred Tax | 9.29 | 1.83 | 9.73 | 2.27 |
| Net Profit | 133.90 | 128.14 | 206.57 | 200.80 |
| Earnings Per Share (₹) – Basic | 0.93 | 0.89 | 1.43 | 1.39 |
| Earnings Per Share (₹) – Diluted | 0.93 | 0.89 | 1.43 | 1.39 |
Operational & Financial Snapshot
- Material cost: ₹7,358.22 lakh (FY25), which is similar to ₹7,318.10 lakh (FY24)
- Employee benefit expenses: ₹219.61 lakh (up from ₹176.48 lakh YoY)
- Cash and cash equivalents at year-end: ₹280.62 lakh
- Inventory: ₹2,582.39 lakh as of March 31, 2025
Operational efficiencies helped the company sustain margins despite rising employee costs.
Audit and Governance
- The company received an unmodified opinion from the statutory auditor, J N Gupta & Co. LLP. This means that the company’s financials are clean.
- The board also disclosed all related party transactions and confirmed no investor complaints were pending at the end of FY25.
Related Party Transactions (Select)
| Party | Nature of Transaction | Amount (₹ in lakh) |
|---|---|---|
| Mr. K. Nagarajarao | Loan taken + Interest + Salary | 176.46 |
| Mrs. Ashalata B. Raut | Loan taken + Interest + Salary | 40.34 |
| M/s Shivadesh Meditex | Sales + Purchase & Labour Charges | 59.14 |
| M/s Moksha Biosurgicals | Rent + Purchase & Labour Charges | 14.11 |
Management Commentary
“We continue to focus on expanding our reach and product innovation in the sterile wound dressing market. Our robust operating performance this year reflects our commitment to quality and efficiency,” said Ashalata Baburao Raut, Managing Director.
Strategic Outlook
Adeshwar Meditex is listed on the SME platform and remains exempt from the IND-AS adoption. As long as its future outlook is concerned, the company aims to focus on growing its domestic and export markets in the wound care segment.
About the Company:
Adeshwar Meditex Ltd is an Indian company that manufactures and exports sterile/non-sterile wound dressings, first aid kits, and medical bandages for hospitals, clinics, and international medical supply chains. The company is headquartered in Palghar, Maharashtra and serves customers in over 20 countries.
REF: https://www.bseindia.com/xml-data/corpfiling/AttachLive/a5eb2fb0-32df-43bc-a618-b1f5fcfb7b91.pdf
